Breast Cancer Coverage from Every Angle

Nicholas C. Turner, MD, PhD, on Using ctDNA Testing in Clinical Practice

Posted: Thursday, December 12, 2019

Nicholas C. Turner, MD, PhD, of The Royal Marsden NHS Foundation Trust, discusses how circulating tumor DNA can be made a realistic part of the posttreatment assessment of patients with advanced breast cancer.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.